Results 201 to 210 of about 4,020,236 (347)
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Evaluation of the Effectiveness of Movement Control Order to Limit the Spread of COVID-19
Md Amiruzzaman +3 more
openalex +1 more source
A New Solution for Freeway Congestion: Cooperative Speed Limit Control Using Distributed Reinforcement Learning [PDF]
Chong Wang +4 more
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Systematic Review of Noise Pollution in Morocco: Regulatory Frameworks, Urban Impacts, and Policy Recommendations. [PDF]
El Malki M +3 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Correction: Limits of Feedback Control in Bacterial Chemotaxis.
doaj +1 more source
Assessment of the stability of 20 biochemical analytes in serum and whole blood samples after storage at nonstandard temperatures. [PDF]
Iacovetti G +10 more
europepmc +1 more source
Collaborative control strategy of power electronic transformer and fault current limiter in DC microgrid [PDF]
Liang Kong, Heng Nian
openalex +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source

